Inventor
UESUGI MOTONARI
JP21 patents
⚠️ This page may combine multiple inventors who share the name “UESUGI MOTONARI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UESUGI MOTONARI
9 patentsUS8207196B2Jun 26, 2012
Compositions and methods for the treatment of metabolic disorders
UESUGI MOTONARI16 citations90
US9187485B2Nov 17, 2015
Methods and compositions for the treatment of cancer and related hyperproliferative disorders
UESUGI MOTONARI6 citations82
US8927578B2Jan 6, 2015
Compositions and methods for the treatment of metabolic disorders
UESUGI MOTONARI8 citations82
US8778976B2Jul 15, 2014
Compositions and methods for the treatment of metabolic disorders
UESUGI MOTONARI6 citations82
US9713613B2Jul 25, 2017
Methods and compositions for the treatment of cancer and related hyperproliferative disorders
UESUGI MOTONARI4 citations71
US9233941B2Jan 12, 2016
Methods and compositions for the treatment of body weight related disorders
UESUGI MOTONARI4 citations71
US9212179B2Dec 15, 2015
Compositions and methods for the treatment of metabolic disorders
UESUGI MOTONARI4 citations71
US9085566B2Jul 21, 2015
Compositions and methods for the treatment of metabolic and related disorders
UESUGI MOTONARI4 citations71
US8685976B2Apr 1, 2014
Cell adhesion promoting agent and method of promoting cell adhesion
UESUGI MOTONARI0 citations36
UNIV KYOTO
5 patentsUS8658425B2Feb 25, 2014
Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells
UNIV KYOTO4 citations71
US9587220B2Mar 7, 2017
Method for inducing cardiac differentiation of pluripotent stem cell
UNIV KYOTO2 citations69
US9499790B2Nov 22, 2016
Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells
UNIV KYOTO1 citations50
US11932595B2Mar 19, 2024
VDR-silent vitamin D derivative as inhibitors of SREBP and pharmaceutical use thereof
UNIV KYOTO0 citations43
US9335323B2May 10, 2016
Method for sorting of pluripotent cells
UNIV KYOTO0 citations34
FGH BIOTECH INC
3 patentsUS11497738B2Nov 15, 2022
Di-substituted pyrazole compounds for the treatment of diseases
FGH BIOTECH INC0 citations49
US11339142B2May 24, 2022
Di-substituted pyrazole compounds for the treatment of diseases
FGH BIOTECH INC0 citations49
US10328064B2Jun 25, 2019
Compositions of fatostatin based heterocyclic compounds and uses thereof
FGH BIOTECH INC0 citations48